Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men

Urology

Volumn 67, Issue 2, 2006, Pages 300-305

  Mullan, Rebecca J ^b   Bergstralh, Eric J ^b   Farmer, Sara A ^b   Jacobson, Debra J ^b   Hebbring, Scott J ^b   Cunningham, Julie M ^b   Thibodeau, Stephen N ^b   Lieber, Michael M ^b   Jacobsen, Steven J ^b   Roberts, Rosebud O ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMMUNITY TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK FACTOR; SCORING SYSTEM; UNITED STATES; URINE FLOW RATE;

ADULT; AGED; CYTOKINES; GROWTH SUBSTANCES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC HYPERPLASIA; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 31944438938     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.08.061     Document Type: Article

References (28)

1. J. Luo, T. Dunn, C. Ewing Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis Prostate 51 2002 189 200
2. K. Griffiths, A.T.K. Cockett, D. Coffey Regulation of prostate growth L. Denis K. Griffiths S. Khoury Proceedings of the Fourth International Consultation on Benign Prostatic Hyperplasia (BPH) vol 4 1998 Health Publication Ltd United Kingdom 83 128
3. C.L. Eaton Aetiology and pathogenesis of benign prostatic hyperplasia Curr Opin Urol 13 2003 7 10
4. R.O. Roberts, D.J. Jacobson, C.J. Girman Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia Am J Epidemiol 157 2003 784 791
5. G. Kramer, G.E. Steiner, A. Handisurya Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation Prostate 52 2002 43 58
6. T. Habuchi, T. Suzuki, R. Sasaki Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population Cancer Res 60 2000 305 308
7. D.G. Blazer III, D.M. Umbach, R.M. Bostick Vitamin D receptor polymorphisms and prostate cancer Mol Carcin 27 2000 18 23
8. R.O. Roberts, E.J. Bergstralh, J.M. Cunningham Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia Am J Epidemiol 159 2004 269 276
9. J.E. Oesterling, S.J. Jacobsen, C.G. Chute Serum prostate-specific antigen in a community-based population of healthy men establishment of age-specific reference ranges JAMA 270 1993 860 864
10. M.J. Barry, F.J.J. Fowler, M.P. O'Leary The American Urological Association Symptom Index for benign prostatic hyperplasia J Urol 148 1992 1549 1557
11. X. Huang, C. Lee Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta Front Biosci 8 2003 s740 s749
12. M. Yokota, S. Ichihara, T.L. Lin Association of a T29- >C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese Circulation 101 2000 2783 2787
13. G.C. Blobe, W.P. Schiemann, H.F. Lodish Role of transforming growth factor beta in human disease N Engl J Med 342 2000 1350 1358
14. Z. Li, T. Habuchi, N. Tsuchiya Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon 10 Carcinogenesis 25 2004 237 240
15. S. Schwartz Jr, C. Caceres, J. Morote Over-expression of epidermal growth factor receptor and c-erbB2/neu but not of INT-2 genes in benign prostatic hyperplasia by means of semi-quantitative PCR Int J Cancer 76 1998 464 467
16. F. Gebhardt, K.S. Zanker, B. Brandt Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1 J Biol Chem 274 1999 13176 13180
17. N. Tidow, A. Boecker, H. Schmidt Distinct amplification of an untranslated regulatory sequence in the EGFR gene contributes to early steps in breast cancer development Cancer Res 63 2003 1172 1178
18. B.B. Aggarwal Signalling pathways of the TNF superfamily a double-edged sword Nat Rev Immunol 3 2003 745 756
19. P. de Miguel, M. Royuela, R. Bethencourt Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates Cytokine 11 1999 722 727
20. A.H. Hajeer, I.V. Hutchinson TNF-alpha gene polymorphism clinical and biological implications Microsc Res Tech 50 2000 216 228
21. J. Ma, M.J. Stampfer, P.H. Gann Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians Cancer Epidemiol Biomarkers Prev 7 1998 385 390
22. T. Carling, J. Rastad, G. Akerstrom Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors J Clin Endocrinol Metab 83 1998 2255 2259
23. H. Mocharla, A.W. Butch, A.A. Pappas Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC lack of correspondence with common allelic variants J Bone Miner Res 12 1997 726 733
24. W. Verbeek, A.F. Gombart, M. Shiohara Vitamin D receptor no evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism Biochem Biophys Res Commun 238 1997 77 80
25. R.O. Roberts, E.J. Bergstralh, S.A. Farmer Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH Prostate 62 2005 380 387
26. L.A. Panser, C.G. Chute, H.A. Guess The natural history of prostatism the effects of non-response bias Int J Epidemiol 23 1994 1198 1205
27. S.J. Jacobsen, D.J. Jacobson, C.J. Girman Natural history of prostatism risk factors for acute urinary retention J Urol 158 1997 481 487
28. R.O. Roberts, M.M. Lieber, T. Rhodes Prevalence of a physician-assigned diagnosis of prostatitis the Olmsted County Study of Urinary Symptoms and Health Status Among Men Urology 51 1998 578 584